GFAP and Alzheimer disease: As expected, astrocyte-specific markers GFAP and AQP4 were higher in 3 × Tg-AD mice compared to WT + Veh mice, which could be attenuated by cornuside treatment, suggesting a suppressive role of cornuside in the activation of astrocytes in 3 × Tg-AD mice (Figure 3a).